Your browser doesn't support javascript.
loading
Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study.
Sun, Feng; Li, Yang; Chen, Yu; Guan, Wenlong; Jiang, Xiangao; Wang, Xiaomeng; Ren, Pengfei; Li, Junlian; Shi, Jichan; He, Guiqing; Wu, Meiying; Tang, Peijun; Wang, Fei; Sheng, Yunfeng; Huang, Fuli; Zhou, Zumo; Huang, Heqing; Hong, Liang; Liu, Qihui; Zhang, Ying; Zhang, Wenhong.
Afiliação
  • Sun F; Dept of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
  • Li Y; These authors contributed equally to this work.
  • Chen Y; Dept of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
  • Guan W; These authors contributed equally to this work.
  • Jiang X; Dept of Tuberculosis, Henan Province Infectious Diseases Hospital, Zhengzhou, China.
  • Wang X; These authors contributed equally to this work.
  • Ren P; The Chest Hospital of Xinjiang Uyghur Autonomous Region, Ürümqi, China.
  • Li J; These authors contributed equally to this work.
  • Shi J; Dept of Infectious Diseases, Wenzhou Central Hospital, Wenzhou, China.
  • He G; These authors contributed equally to this work.
  • Wu M; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
  • Tang P; These authors contributed equally to this work.
  • Wang F; Dept of Tuberculosis, Henan Province Infectious Diseases Hospital, Zhengzhou, China.
  • Sheng Y; The Chest Hospital of Xinjiang Uyghur Autonomous Region, Ürümqi, China.
  • Huang F; Dept of Infectious Diseases, Wenzhou Central Hospital, Wenzhou, China.
  • Zhou Z; Dept of Infectious Diseases, Wenzhou Central Hospital, Wenzhou, China.
  • Huang H; Suzhou Fifth People's Hospital, Suzhou, China.
  • Hong L; Suzhou Fifth People's Hospital, Suzhou, China.
  • Liu Q; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
  • Zhang Y; Tuberculosis Treatment Center, Hangzhou Red Cross Hospital, Hangzhou, China.
  • Zhang W; Dept of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Eur Respir J ; 53(3)2019 03.
Article em En | MEDLINE | ID: mdl-30578402
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinamida / Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Eur Respir J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinamida / Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Eur Respir J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido